Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Resident, Medicine, Stanford University School of Medicine 1990 - 1991
  • Intern, Medicine, Stanford University School of Medicine 1989 - 1990
  • M.D., Stanford University 1989
• 

  Duke Appointment History

  • Instructor, Temporary in the Department of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2013 - 2015
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Anand, S, Thomas, S, Hyslop, T, Adcock, J, Corbet, K, Gasparetto, C, Lopez, R, Long, GD, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, and Horwitz, ME. "Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 23, no. 7 (July 2017): 1151-1157.  Full Text
    • Sivaraj, D, Green, MM, Li, Z, Sung, AD, Sarantopoulos, S, Kang, Y, Long, GD, Horwitz, ME, Lopez, RD, Sullivan, KM, Rizzieri, DA, Chao, NJ, and Gasparetto, C. "Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 23, no. 2 (February 2017): 262-268.  Full Text
    • Bonneville, M, Chen, ZW, Déchanet-Merville, J, Eberl, M, Fournié, JJ, Jameson, JM, Lopez, RD, Massaia, M, and Silva-Santos, B. "Chicago 2014 – 30years of γδ T cells." Cellular Immunology 296, no. 1 (July 2015): 3-9.  Full Text
    • Xu, H-G, Zhai, Y-X, Chen, J, Lu, Y, Wang, J-W, Quan, C-S, Zhao, R-X, Xiao, X, He, Q, Werle, KD, Kim, H-G, Lopez, R, Cui, R, Liang, J, Li, Y-L, and Xu, Z-X. "LKB1 reduces ROS-mediated cell damage via activation of p38." Oncogene 34, no. 29 (July 2015): 3848-3859.  Full Text
    • Beck, BH, Kim, H, O'Brien, R, Jadus, MR, Gillespie, GY, Cloud, GA, Hoa, NT, Langford, CP, Lopez, RD, Harkins, LE, and Lamb, LS. "Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma." PloS one 10, no. 5 (January 2015): e0122387-.  Full Text
    • Lopez, RD. "Inhibiting inhibitory pathways in human γδ T cells." Blood 122, no. 6 (August 8, 2013): 857-858.  Full Text  Link to Item
    • Lindhorst, SM, Lopez, RD, and Sanders, RD. "An unusual presentation of chronic myelogenous leukemia: a review of isolated central nervous system relapse." Journal of the National Comprehensive Cancer Network : Jnccn 11, no. 7 (July 2013): 745-750.  Full Text
    • Beck, B, Gillespie, GY, Lopez, RD, Cloud, GA, Langford, C, Kim, H, Harkins, L, and Lamb, LS. "Abstract 530: Circulating γδ T cells are activated and depleted during progression of high-grade gliomas: Implications for γδ T cells therapy of GBM." Cancer Research 72, no. 8 Supplement (April 15, 2012): 530-530.  Full Text
    • Kanda, J, Lopez, RD, and Rizzieri, DA. "Alemtuzumab for the prevention and treatment of graft-versus-host disease." International Journal of Hematology 93, no. 5 (May 2011): 586-593. (Review)  Full Text
    • Bryant, NL, Gillespie, GY, Lopez, RD, Markert, JM, Cloud, GA, Langford, CP, Arnouk, H, Su, Y, Haines, HL, Suarez-Cuervo, C, and Lamb, LS. "Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme." Journal of Neuro Oncology 101, no. 2 (January 2011): 179-188.  Full Text
    • Kanda, J, Lopez, RD, and Rizzieri, DA. "Alemtuzumab for the prevention and treatment of graft-versus-host disease." International Journal of Hematology (2011): 1-8.  Full Text
    • Beck, BH, Kim, H-G, Kim, H, Samuel, S, Liu, Z, Shrestha, R, Haines, H, Zinn, K, and Lopez, RD. "Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer." Breast Cancer Res Treat 122, no. 1 (July 2010): 135-144.  Full Text  Link to Item
    • Bryant, NL, Suarez-Cuervo, C, Gillespie, GY, Markert, JM, Nabors, LB, Meleth, S, Lopez, RD, and Lamb, LS. "Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma." Neuro Oncol 11, no. 4 (August 2009): 357-367.  Full Text  Link to Item
    • Liu, Z, Guo, B, and Lopez, RD. "Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer." J Gastroenterol Hepatol 24, no. 5 (May 2009): 900-911.  Full Text  Link to Item
    • Liu, Z, Eltoum, I-EA, Guo, B, Beck, BH, Cloud, GA, and Lopez, RD. "Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer." J Immunol 180, no. 9 (May 1, 2008): 6044-6053.  Link to Item
    • Suarez-Cuervo, C, Bryant, NL, Lopez, RD, Gillespie, GY, and Lamb, LS. "Ex vivo activation and expansion of γδ T cells for immunotherapy of glioblastoma." J Clin Oncol 24, no. 18_suppl (June 20, 2006): 2553-null.  Link to Item
    • Guo, BL, Liu, Z, Aldrich, WA, and Lopez, RD. "Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells." Breast Cancer Research and Treatment 93, no. 2 (September 2005): 169-175.  Full Text
    • Liu, Z, Guo, BL, Gehrs, BC, Nan, L, and Lopez, RD. "Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro." J Urol 173, no. 5 (May 2005): 1552-1556.  Link to Item
    • Lamb, LS, and Lopez, RD. "gammadelta T cells: a new frontier for immunotherapy?." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 11, no. 3 (March 2005): 161-168. (Review)  Full Text
    • Lamb, LS, and Lopez, RD. "γδ T cells: A new frontier for immunotherapy?." Biology of Blood and Marrow Transplantation 11, no. 3 (March 2005): 161-168.  Full Text
    • Guo, BL, Hollmig, KA, and Lopez, RD. "Down-regulation of IL-2 receptor alpha (CD25) characterizes human gammadelta-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12." Cancer Immunol Immunother 50, no. 11 (January 2002): 625-637.  Full Text  Link to Item
    • Lopez, RD. "Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases." Immunol Res 26, no. 1-3 (2002): 207-221. (Review)  Full Text  Link to Item
    • Vaughan, WP, Katz, RO, Salzman, DE, Tilden, AB, Lopez, RD, Garcia, A, Pena, O, Shackelford, M, and Carabasi, MH. "MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD." BLOOD 98, no. 11 (November 16, 2001): 200A-200A.  Link to Item
    • Lopez, RD, Waller, EK, Lu, PH, and Negrin, RS. "CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56+ T cells." Cancer Immunol Immunother 49, no. 12 (February 2001): 629-640.  Link to Item
    • "Adoptive immunotherapy with allogeneic EBV CTL for organ transplant patients with ebv induced lymphoproliferative disease." Blood 96, no. 11 PART II (December 1, 2000).
    • Lopez, RD, Xu, S, Guo, B, Negrin, RS, and Waller, EK. "CD2-mediated IL-12-dependent signals render human γδ-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: Implications for the development of adoptive immunotherapy strategies." Blood 96, no. 12 (December 1, 2000): 3827-3837.
    • Negrin, RS. "CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56⁺T cells." Cancer Immunology, Immunotherapy 49, no. 11 (December 1, 2000): 629-640.
    • Sherman, MA, Secor, VH, Lee, SK, Lopez, RD, and Brown, MA. "STAT6-independent production of IL-4 by mast cells." European Journal of Immunology 29, no. 4 (April 1999): 1235-1242.  Full Text
    • "Engagement of CD2/LFA-2 on activated human peripheral blood T cells results in an IL-12-dependent resistance to Activation-Induced Cell Death (AICD) in γδ T cells." Faseb Journal 12, no. 5 (March 20, 1998).
    • Margulies, DH, Lopez, R, Boyd, LF, and McCluskey, J. "Engineering soluble major histocompatibility molecules: why and how." Immunologic research 6, no. 1-2 (January 1987): 101-116. (Review)  Full Text

  • Conference Papers

    • Anand, S, Thomas, S, Corbet, K, Gasparetto, C, Long, GD, Lopez, R, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, and Horwitz, ME. "Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning." November 2017.  Full Text
    • Beck, B, Lopez, RD, Gillespie, GY, Kim, H, Cloud, G, Pereboeva, L, and Jr, LLS. "Peripheral Blood gamma delta T Cell Response to High-Grade Glioma: Implications for Localized Adoptive Immunotherapy." November 16, 2012.  Link to Item
    • Beck, B, Lopez, RD, Gillespie, GY, Kim, H, Cloud, G, Pereboeva, L, and Jr, LLS. "Peripheral Blood gamma delta T Cell Response to High-Grade Glioma: Implications for Localized Adoptive Immunotherapy." November 16, 2012.  Link to Item
    • Suarez, C, Bryant, NL, Gillespie, Y, Lopez, RD, Markert, JM, and Lamb, LS. "189: γδ T cells as immunotherapy for glioblastoma multiforme." : Elsevier BV, February 2007.  Full Text
    • Suarez-Cuervo, C, Bryant, NL, Lopez, RD, Gillespie, GY, and Lamb, LS. "Ex vivo activation and expansion of gamma delta T cells for immunotherapy of glioblastorna." June 20, 2006.  Link to Item
    • Gehrs, BC, and Lopez, RD. "Ex vivo expansion of gamma delta-T lymphocytes from melanoma patients and healthy control donors." September 2005.  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.